Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maltodextrin + fructose is a combination of two carbohydrates commonly used in sports nutrition, particularly for endurance athletes. Maltodextrin is a glucose polymer that is rapidly digested and absorbed, providing quick energy to muscles. Fructose, on the other hand, uses a different intestinal transporter (GLUT5) than maltodextrin (which uses SGLT1), allowing for simultaneous absorption and higher total carbohydrate uptake rates compared to single-carbohydrate solutions[6][7]. This combination enables greater exogenous carbohydrate oxidation during prolonged exercise—up to 40% higher than maltodextrin alone—and can support intake rates up to 90 grams per hour or more without significant gastrointestinal distress[1][3][7]. The dual transport mechanism also helps reduce fatigue and perceived exertion during endurance activities[6]. Maltodextrin primarily replenishes muscle glycogen while fructose aids in liver glycogen recovery[8]. The mixture has been shown to acutely mitigate inflammation during intense exercise when used at an optimal ratio (commonly 2:1 maltodextrin-to-fructose)[9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on maltodextrin + fructose.